| Market Cap | 61.46M | P/E | - | EPS this Y | -219.70% | Ern Qtrly Grth | - |
| Income | -235.52M | Forward P/E | -3.04 | EPS next Y | 91.50% | 50D Avg Chg | -3.00% |
| Sales | 85.89M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -4.00% |
| Dividend | N/A | Price/Book | 0.77 | EPS next 5Y | - | 52W High Chg | -75.00% |
| Recommedations | 1.00 | Quick Ratio | 1.04 | Shares Outstanding | 80.74M | 52W Low Chg | 31.00% |
| Insider Own | 13.11% | ROA | -23.46% | Shares Float | 71.01M | Beta | 1.82 |
| Inst Own | 14.79% | ROE | -146.54% | Shares Shorted/Prior | 320.01K/405.75K | Price | 0.76 |
| Gross Margin | -3.53% | Profit Margin | -274.21% | Avg. Volume | 118,925 | Target Price | - |
| Oper. Margin | -115.15% | Earnings Date | Feb 27 | Volume | 44,625 | Change | 0.00% |
The Valens Company Inc., through its subsidiaries, develops, manufactures, and sells cannabinoid-based products in Canada, the United States, and internationally. The company provides packaged dried flower/pre-rolls under the Verse, Versus, Contraband, and Citizen Stash brands; vapourizers and hydrocarbon extracts under the Verse and Versus brands; edible cannabis products under the Verse, Vacay, and LYF brands; and topical cannabis under the Nuance brand. It also offers analytical testing services to third party licensed producers in the cannabis space. The company is headquartered in Toronto, Canada.
